Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

被引:45
作者
Zarka, Jabra [1 ]
Short, Nicholas J. [1 ]
Kanagal-Shamanna, Rashmi [2 ]
Issa, Ghayas C. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
AML; nucleophosmin (NPM1); gene expression; targeted therapies; TUMOR-SUPPRESSOR PROTEIN; ACUTE MYELOGENOUS LEUKEMIA; MINIMAL RESIDUAL DISEASE; GENE-EXPRESSION PROFILE; NPM1; MUTATIONS; CLONAL HEMATOPOIESIS; MUTANT NUCLEOPHOSMIN; RIBOSOME BIOGENESIS; RETINOIC ACID; CYTOPLASMIC NUCLEOPHOSMIN;
D O I
10.3390/genes11060649
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein involved in ribosome biogenesis, the maintenance of genomic integrity and the regulation of the ARF-p53 tumor-suppressor pathway among multiple other functions. Mutations in the corresponding gene cause a cytoplasmic dislocation of the NPM1 protein. These mutations are unique to acute myeloid leukemia (AML), a disease characterized by clonal expansion, impaired differentiation and the proliferation of myeloid cells in the bone marrow. Despite our improved understanding ofNPM1mutations and their consequences, the underlying leukemia pathogenesis is still unclear. Recent studies that focused on dysregulated gene expression in AML with mutatedNPM1have shed more light into these mechanisms. In this article, we review the current evidence on normal functions of NPM1 and aberrant functioning in AML, and highlight investigational strategies targeting these mutations.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [1] Nucleophosmin mutations in acute myeloid leukemia: A tale of protein unfolding and mislocalization
    Federici, Luca
    Falini, Brunangelo
    PROTEIN SCIENCE, 2013, 22 (05) : 545 - 556
  • [2] Role of nucleophosmin in acute myeloid leukemia
    Meani, Natalia
    Alcalay, Myriam
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (09) : 1283 - 1294
  • [3] Prognostic Involvement of Nucleophosmin Mutations in Acute Myeloid Leaukemia
    Shahab, Sadaf
    Shamsi, Tahir Sultan
    Ahmed, Nuzhat
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (10) : 5615 - 5620
  • [4] Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia
    Ruan, Guo-Rui
    Li, Jin-Lan
    Qin, Ya-Zhen
    Li, Ling-Di
    Xie, Min
    Chang, Yan
    Zhang, Yan
    Liu, Yan-Rong
    Jiang, Bin
    Chen, Shan-Shan
    Huang, Xiao-Jun
    ANNALS OF HEMATOLOGY, 2009, 88 (02) : 159 - 166
  • [5] Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
    Falini, Brunangelo
    Martelli, Maria Paola
    Bolli, Niccolo
    Sportoletti, Paolo
    Liso, Arcangelo
    Tiacci, Enrico
    Haferlach, Torsten
    BLOOD, 2011, 117 (04) : 1109 - 1120
  • [6] Driver mutations in acute myeloid leukemia
    Kishtagari, Ashwin
    Levine, Ross L.
    Viny, Aaron D.
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (02) : 49 - 57
  • [7] Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity
    Rau, Rachel
    Brown, Patrick
    HEMATOLOGICAL ONCOLOGY, 2009, 27 (04) : 171 - 181
  • [8] Quantitative Assay of Mutated Nucleophosmin in Acute Myeloid Leukemia
    Khaled, Safaa A. A.
    Burthem, John
    Elnoor, El-Badry E. Abo
    ElToni, Lobna F.
    Ahmed, Hanan M.
    Ahmed, Sohier M.
    JOURNAL OF HEMATOLOGY, 2019, 8 (03) : 111 - 120
  • [9] Clinical usefulness of plasma specimens for detection of nucleophosmin 1 gene mutations in patients with normal karyotype acute myeloid leukemia
    Park, Sang Hyuk
    Min, Sook-Kyung
    Park, Borae G.
    Jang, Seongsoo
    Park, Chan-Jeoung
    Chi, Hyun-Sook
    LEUKEMIA RESEARCH, 2011, 35 (09) : E159 - E160
  • [10] Prognostic Impact of Nucleophosmin 1 (NPM1) Gene Mutations in Egyptian Acute Myeloid Leukemia Patients
    Zidan, Magda
    Shaaban, Howyda
    El Ghannam, Doaa
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (02) : 129 - 136